Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Oct;14(10):4055–4072. doi: 10.21037/jtd-22-1185

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

2022 Journal of Thoracic Disease. All rights reserved.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0.

PMC Copyright notice

Correlations between the prognostic m6A-related lncRNAs and the clinical characteristics. (A) Clinical characteristics and m6A-related lncRNA expression patterns of patients in the 2 clusters. (B) Kaplan-Meier curves of patients in cluster A and cluster B. PD-L1, PD-L2, and CTLA4 expressions in cluster A and cluster B. (C) PD-L1. (D) PD-L2. (E) CTLA4. (F) The correlations between PD-L1, PD-L2, and CTLA4 with prognostic m6A-related lncRNAs. (G) Immune cell infiltration in cluster A and cluster B. (H) Immune score in cluster A and cluster B. (I) Stromal score in cluster A and cluster B. (J) ESTIMATE score in cluster A and cluster B. **, P<0.01; ***, P<0.001. N, node; M, metastasis; T, tumor; m6A, N6-methylandenosine; lncRNA, long non-coding RNA; PD-L1, programmed death-ligand 1; PD-L2, programmed death-ligand 2; CTLA4, cytotoxic T-lymphocyte-associated protein 4.